Eslit, Cassy I.
HRN: 22-35-23 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/22/2022
CEFTAZIDIME 1GM (VIAL)
12/22/2022
12/29/2022
IV
60mg
Q8
RaGT Confirmed Covid19 Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes